Eli Lilly Invests $5bn in Virginia
Article excerpt
Highlighted: the sentence this signal was extracted from
The pharmaceutical giant today broke ground on a new $5bn production site located west of Richmond, in Goochland County, Virginia. Jean-Yves Courtial Published on 10/23/2026 at 02:25 am EDT The facility is part of an investment plan of more than $50bn aimed at increasing the group's drug manufacturing capacity in the United States. It is the tenth new production site announced by the group in the United States since 2020, and the fifth dedicated to the manufacture of active pharmaceutical ingredients (APIs). The Richmond site marks a key step in the company's industrial organization: it will become Eli Lilly's first fully integrated plant capable of handling both the production of active pharmaceutical ingredients and the packaging of finished drugs. The facility will have dedicated capacity for manufacturing APIs for bioconjugate drugs and high-molecular-weight molecules.